Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 401

1.

Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B.

Mizushima E, Tsukahara T, Emori M, Murata K, Akamatsu A, Shibayama Y, Hamada S, Watanabe Y, Kaya M, Hirohashi Y, Kanaseki T, Nakatsugawa M, Kubo T, Yamashita T, Sato N, Torigoe T.

Cancer Sci. 2019 Nov 9. doi: 10.1111/cas.14229. [Epub ahead of print]

2.

Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.

Kubo T, Kikuchi N, Shiina S, Torigoe T, Iwaki H.

Auris Nasus Larynx. 2019 Oct 22. pii: S0385-8146(19)30444-4. doi: 10.1016/j.anl.2019.10.001. [Epub ahead of print]

PMID:
31653481
3.

Proteogenomic discovery of cancer antigens: Neoantigens and beyond.

Kanaseki T, Tokita S, Torigoe T.

Pathol Int. 2019 Sep;69(9):511-518. doi: 10.1111/pin.12841. Epub 2019 Aug 9. Review.

PMID:
31397525
4.

Proteogenomics: advances in cancer antigen research.

Kanaseki T, Torigoe T.

Immunol Med. 2019 Jun;42(2):65-70. doi: 10.1080/25785826.2019.1640500. Epub 2019 Jul 18.

PMID:
31318319
5.

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA-A24-positive pancreatic adenocarcinoma.

Shima H, Tsurita G, Wada S, Hirohashi Y, Yasui H, Hayashi H, Miyakoshi T, Watanabe K, Murai A, Asanuma H, Tokita S, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Nakae Y, Sugita O, Ito YM, Ota Y, Kimura Y, Kutomi G, Hirata K, Mizuguchi T, Imai K, Takemasa I, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2378-2385. doi: 10.1111/cas.14106. Epub 2019 Jul 23.

6.

Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series.

Kubo T, Tsurita G, Hirohashi Y, Yasui H, Ota Y, Watanabe K, Murai A, Matsuo K, Asanuma H, Shima H, Wada S, Nakatsugawa M, Kanaseki T, Tsukahara T, Mizuguchi T, Hirata K, Takemasa I, Imai K, Sato N, Torigoe T.

Cancer Sci. 2019 Aug;110(8):2386-2395. doi: 10.1111/cas.14099. Epub 2019 Jul 11.

7.

[PD-L1-Mediated Immune Escape Mechanism of Cancer Stem-Like Cells].

Matsuki M, Hirohashi Y, Torigoe T.

Gan To Kagaku Ryoho. 2019 May;46(5):850-854. Review. Japanese.

PMID:
31189802
8.

2-Position-Selective Trifluoromethylthiolation of Six-Membered Heteroaromatic Compounds.

Muta R, Torigoe T, Kuninobu Y.

Org Lett. 2019 Jun 7;21(11):4289-4292. doi: 10.1021/acs.orglett.9b01474. Epub 2019 May 16.

PMID:
31094532
9.

ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD.

Kawai N, Hirohashi Y, Ebihara Y, Saito T, Murai A, Saito T, Shirosaki T, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Shichinohe T, Li L, Hirano S, Torigoe T.

PLoS One. 2019 May 13;14(5):e0216503. doi: 10.1371/journal.pone.0216503. eCollection 2019.

10.

Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report.

Honjo O, Kubo T, Sugaya F, Nishizaka T, Kato K, Hirohashi Y, Takahashi H, Torigoe T.

J Immunother Cancer. 2019 Apr 3;7(1):97. doi: 10.1186/s40425-019-0582-4.

11.

Upstream Position of Proline Defines Peptide-HLA Class I Repertoire Formation and CD8+ T Cell Responses.

Hongo A, Kanaseki T, Tokita S, Kochin V, Miyamoto S, Hashino Y, Codd A, Kawai N, Nakatsugawa M, Hirohashi Y, Sato N, Torigoe T.

J Immunol. 2019 May 15;202(10):2849-2855. doi: 10.4049/jimmunol.1900029. Epub 2019 Apr 1.

PMID:
30936292
12.

The impact of antecedent primary malignancy in soft tissue sarcoma patients.

Torigoe T, Imanishi J, Yazawa Y, Kadono Y, Oda H.

J Orthop Surg (Hong Kong). 2019 May-Aug;27(2):2309499019838124. doi: 10.1177/2309499019838124.

PMID:
30909802
13.

Identification of novel human leukocyte antigen-A*11:01-restricted cytotoxic T-lymphocyte epitopes derived from osteosarcoma antigen papillomavirus binding factor.

Li D, Toji S, Watanabe K, Torigoe T, Tsukahara T.

Cancer Sci. 2019 Apr;110(4):1156-1168. doi: 10.1111/cas.13973. Epub 2019 Mar 12.

14.

Efficacy of combined radiotherapy and anti-programmed death 1 therapy in acral and mucosal melanoma.

Kato J, Hida T, Someya M, Sato S, Sawada M, Horimoto K, Fujioka M, Minowa T, Matsui Y, Tsuchiya T, Kitagawa M, Nakata K, Sakata KI, Torigoe T, Uhara H.

J Dermatol. 2019 Apr;46(4):328-333. doi: 10.1111/1346-8138.14805. Epub 2019 Feb 13.

PMID:
30758859
15.

Hydrogen-Bond-Controlled Formal Meta-Selective C-H Transformations and Regioselective Synthesis of Multisubstituted Aromatic Compounds.

Wang J, Torigoe T, Kuninobu Y.

Org Lett. 2019 Mar 1;21(5):1342-1346. doi: 10.1021/acs.orglett.9b00030. Epub 2019 Feb 8.

PMID:
30735396
16.

Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.

Tabuchi Y, Hirohashi Y, Hashimoto S, Mariya T, Asano T, Ikeo K, Kuroda T, Mizuuchi M, Murai A, Uno S, Kawai N, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Saito T, Torigoe T.

Exp Mol Pathol. 2019 Feb;106:78-88. doi: 10.1016/j.yexmp.2018.11.013. Epub 2018 Nov 30.

PMID:
30503404
17.

Association between PD-L1 expression and lymph node metastasis in cutaneous squamous cell carcinoma.

Kamiya S, Kato J, Kamiya T, Yamashita T, Sumikawa Y, Hida T, Horimoto K, Sato S, Takahashi H, Sawada M, Kubo T, Torigoe T, Uhara H.

Asia Pac J Clin Oncol. 2018 Nov 8. doi: 10.1111/ajco.13102. [Epub ahead of print]

PMID:
30411509
18.

Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.

Kubo T, Hirohashi Y, Fujita H, Sugita S, Kikuchi Y, Shinkawa T, Nakatsugawa M, Tsujiwaki M, Sudo Y, Asai Y, Umeda Y, Takahashi H, Hasegawa T, Torigoe T.

Respir Med Case Rep. 2018 Oct 18;25:306-308. doi: 10.1016/j.rmcr.2018.10.013. eCollection 2018.

19.

Treatment of fetal circular shunt with non-steroidal anti-inflammatory drugs.

Torigoe T, Mawad W, Seed M, Ryan G, Marini D, Golding F, VAN Mieghem T, Jaeggi E.

Ultrasound Obstet Gynecol. 2019 Jun;53(6):841-846. doi: 10.1002/uog.20169.

PMID:
30381862
20.

Development of a T-cell receptor multimer with high avidity for detecting a naturally presented tumor-associated antigen on osteosarcoma cells.

Watanabe K, Tsukahara T, Toji S, Saitoh S, Hirohashi Y, Nakatsugawa M, Kubo T, Kanaseki T, Kameshima H, Terui T, Sato N, Torigoe T.

Cancer Sci. 2019 Jan;110(1):40-51. doi: 10.1111/cas.13854. Epub 2018 Dec 1.

21.

The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer.

Abe Y, Nakayama Y, Katsuki T, Inoue Y, Minagawa N, Torigoe T, Higure A, Sako T, Nagata N, Hirata K.

Asia Pac J Clin Oncol. 2019 Apr;15(2):e49-e55. doi: 10.1111/ajco.13077. Epub 2018 Sep 30.

PMID:
30270512
22.

Differential bronchial epithelial response regulated by ΔNp63: a functional understanding of the epithelial shedding found in asthma.

Kubo T, Tsujiwaki M, Hirohashi Y, Tsukahara T, Kanaseki T, Nakatsugawa M, Hasegawa T, Torigoe T.

Lab Invest. 2019 Feb;99(2):158-168. doi: 10.1038/s41374-018-0132-6. Epub 2018 Sep 25.

PMID:
30254318
23.

Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma.

Fukushima Y, Someya M, Nakata K, Hori M, Kitagawa M, Hasegawa T, Tsuchiya T, Gocho T, Ikeda H, Hirohashi Y, Torigoe T, Sugita S, Hasegawa T, Himi T, Sakata KI.

Radiother Oncol. 2018 Nov;129(2):409-414. doi: 10.1016/j.radonc.2018.08.023. Epub 2018 Sep 21.

PMID:
30249348
24.

Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine.

Shima H, Kutomi G, Satomi F, Imamura M, Kimura Y, Mizuguchi T, Watanabe K, Takahashi A, Murai A, Tsukahara T, Kanaseki T, Hirohashi Y, Iwayama Y, Tsuruma T, Kameshima H, Sato N, Torigoe T, Takemasa I.

Cancer Immunol Immunother. 2018 Oct;67(10):1603-1609. doi: 10.1007/s00262-018-2217-x. Epub 2018 Aug 1.

25.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J.

Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10.

PMID:
29754777
26.

Minimal Shortening of Leukocyte Telomere Length Across Age Groups in a Cross-Sectional Study for Carriers of a Longevity-Associated FOXO3 Allele.

Davy PMC, Willcox DC, Shimabukuro M, Donlon TA, Torigoe T, Suzuki M, Higa M, Masuzaki H, Sata M, Chen R, Murkofsky RL, Morris BJ, Lim E, Allsopp RC, Willcox BJ.

J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1448-1452. doi: 10.1093/gerona/gly071. Erratum in: J Gerontol A Biol Sci Med Sci. 2019 Jan 16;74(2):192.

27.

Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.

Aoyama-Kikawa S, Fujita H, Hanley SJB, Kasamo M, Kikuchi K, Torigoe T, Matsuno Y, Tamakoshi A, Sasaki T, Matsuura M, Kato Y, Dong P, Watari H, Saito T, Sengoku K, Sakuragi N.

Cancer Sci. 2018 Jun;109(6):2003-2012. doi: 10.1111/cas.13608. Epub 2018 May 31.

28.

Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced Melanoma.

Kato J, Hida T, Kamiya T, Sato S, Takahashi H, Torigoe T, Uhara H.

JAMA Dermatol. 2018 May 1;154(5):621-622. doi: 10.1001/jamadermatol.2017.6400. No abstract available.

PMID:
29590278
29.

Corrigendum to "Flow cytometric quantitation of platelet phagocytosis by monocytes using a pH-sensitive dye, pHrodo-SE" [Journal of Immunological Methods 447 (2017) 57-64].

Takahashi D, Fujihara M, Miyazaki T, Matsubayashi K, Sato S, Azuma H, Kato T, Kino S, Ikeda H, Takamoto S, Sato N, Torigoe T.

J Immunol Methods. 2018 Mar;454:89. doi: 10.1016/j.jim.2018.02.001.

PMID:
29455735
30.

The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer.

Miyamoto S, Kochin V, Kanaseki T, Hongo A, Tokita S, Kikuchi Y, Takaya A, Hirohashi Y, Tsukahara T, Terui T, Ishitani K, Hata F, Takemasa I, Miyazaki A, Hiratsuka H, Sato N, Torigoe T.

Cancer Immunol Res. 2018 Mar;6(3):358-369. doi: 10.1158/2326-6066.CIR-17-0518. Epub 2018 Jan 25.

31.

ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.

Ogawa T, Hirohashi Y, Murai A, Nishidate T, Okita K, Wang L, Ikehara Y, Satoyoshi T, Usui A, Kubo T, Nakastugawa M, Kanaseki T, Tsukahara T, Kutomi G, Furuhata T, Hirata K, Sato N, Mizuguchi T, Takemasa I, Torigoe T.

Oncotarget. 2017 Nov 8;8(68):112550-112564. doi: 10.18632/oncotarget.22545. eCollection 2017 Dec 22.

32.

Cellular stress induces cancer stem-like cells through expression of DNAJB8 by activation of heat shock factor 1.

Kusumoto H, Hirohashi Y, Nishizawa S, Yamashita M, Yasuda K, Murai A, Takaya A, Mori T, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Kondo T, Sato N, Hara I, Torigoe T.

Cancer Sci. 2018 Mar;109(3):741-750. doi: 10.1111/cas.13501. Epub 2018 Feb 20.

33.

Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.

Katsuki T, Nakayama Y, Akiyama M, Sawatsubashi Y, Nagata J, Minagawa N, Torigoe T, Izumi H, Kohono K, Hirata K.

Anticancer Res. 2018 Jan;38(1):569-575.

PMID:
29277826
34.

Evaluation of pancreatic exocrine insufficiency by cine-dynamic MRCP using spatially selective inversion-recovery (IR) pulse: Correlation with severity of chronic pancreatitis based on morphological changes of pancreatic duct.

Yasokawa K, Ito K, Kanki A, Yamamoto A, Torigoe T, Sato T, Tamada T.

Magn Reson Imaging. 2018 May;48:70-73. doi: 10.1016/j.mri.2017.12.007. Epub 2017 Dec 5.

PMID:
29217490
35.

Identification of antigenic peptides from novel renal cancer stem-like cell antigen, DNAJB8.

Nishizawa S, Hirohashi Y, Kusumoto H, Wakamiya T, Iguchi T, Yamashita S, Iba A, Kikkawa K, Kohjimoto Y, Torigoe T, Hara I.

Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):693-699. doi: 10.1016/j.bbrc.2017.10.146. Epub 2017 Oct 28.

PMID:
29107688
36.

Comprehensive single-cell transcriptome analysis reveals heterogeneity in endometrioid adenocarcinoma tissues.

Hashimoto S, Tabuchi Y, Yurino H, Hirohashi Y, Deshimaru S, Asano T, Mariya T, Oshima K, Takamura Y, Ukita Y, Ametani A, Kondo N, Monma N, Takeda T, Misu S, Okayama T, Ikeo K, Saito T, Kaneko S, Suzuki Y, Hattori M, Matsushima K, Torigoe T.

Sci Rep. 2017 Oct 27;7(1):14225. doi: 10.1038/s41598-017-14676-3.

37.

Asymmetric Cycloisomerization of o-Alkenyl-N-Methylanilines to Indolines by Iridium-Catalyzed C(sp3 )-H Addition to Carbon-Carbon Double Bonds.

Torigoe T, Ohmura T, Suginome M.

Angew Chem Int Ed Engl. 2017 Nov 6;56(45):14272-14276. doi: 10.1002/anie.201708578. Epub 2017 Oct 16.

PMID:
28948685
38.

Novel technique of abdominal wall nerve block for laparoscopic colostomy: Rectus sheath block with transperitoneal approach.

Nagata J, Watanabe J, Sawatsubashi Y, Akiyama M, Arase K, Minagawa N, Torigoe T, Hamada K, Nakayama Y, Hirata K.

World J Gastrointest Surg. 2017 Aug 27;9(8):182-185. doi: 10.4240/wjgs.v9.i8.182.

39.

Induction and Analysis of Cytotoxic T-Lymphocytes that Recognize Autologous Oral Squamous Cell Carcinoma.

Okamoto JY, Miyazaki A, Kobayashi JI, Miyamoto S, Sasaki T, Kanaseki T, Hirohashi Y, Torigoe T, Hiratsuka H.

Anticancer Res. 2017 Sep;37(9):4889-4897.

PMID:
28870910
40.

Transperitoneal rectus sheath block and transversus abdominis plane block for laparoscopic inguinal hernia repair: A novel approach.

Nagata J, Watanabe J, Nagata M, Sawatsubashi Y, Akiyama M, Tajima T, Arase K, Minagawa N, Torigoe T, Nakayama Y, Horishita R, Kida K, Hamada K, Hirata K.

Asian J Endosc Surg. 2017 Aug;10(3):336-338. doi: 10.1111/ases.12370.

PMID:
28727314
41.

Implication of chemo-resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy.

Shibayama Y, Tsukahara T, Emori M, Murata K, Mizushima E, Hirohashi Y, Kanaseki T, Nakatsugawa M, Kubo T, Yamashita T, Sato N, Torigoe T.

Cancer Sci. 2017 Sep;108(9):1739-1745. doi: 10.1111/cas.13319. Epub 2017 Aug 7.

42.

Immune-related adverse events of immune checkpoint inhibitors.

Tadano H, Torigoe T.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(2):102-108. doi: 10.2177/jsci.40.102. Review. Japanese.

43.

Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy.

Miyamoto S, Kanaseki T, Hirohashi Y, Tsukahara T, Kikuchi Y, Sato N, Torigoe T.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(1):40-47. doi: 10.2177/jsci.40.40. Review. Japanese.

44.

HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses.

Kochin V, Kanaseki T, Tokita S, Miyamoto S, Shionoya Y, Kikuchi Y, Morooka D, Hirohashi Y, Tsukahara T, Watanabe K, Toji S, Kokai Y, Sato N, Torigoe T.

Oncoimmunology. 2017 Feb 16;6(4):e1293214. doi: 10.1080/2162402X.2017.1293214. eCollection 2017.

45.

Flow cytometric quantitation of platelet phagocytosis by monocytes using a pH-sensitive dye, pHrodo-SE.

Takahashi D, Fujihara M, Miyazaki T, Matsubayashi K, Sato S, Azuma H, Kato T, Kino S, Ikeda H, Takamoto S, Sato N, Torigoe T.

J Immunol Methods. 2017 Aug;447:57-64. doi: 10.1016/j.jim.2017.04.009. Epub 2017 May 1. Erratum in: J Immunol Methods. 2018 Mar;454:89.

PMID:
28472622
46.

Improvement of pulmonary arterial hypertension following medication and shunt closure in a BMPR2 mutation carrier with atrial septal defect.

Suzuki H, Hanawa H, Torigoe T, Sato S.

J Cardiol Cases. 2017 Apr 26;16(1):11-13. doi: 10.1016/j.jccase.2017.03.005. eCollection 2017 Jul.

47.

GRIK2 has a role in the maintenance of urothelial carcinoma stem-like cells, and its expression is associated with poorer prognosis.

Inoue R, Hirohashi Y, Kitamura H, Nishida S, Murai A, Takaya A, Yamamoto E, Matsuki M, Tanaka T, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Sato N, Masumori N, Torigoe T.

Oncotarget. 2017 Apr 25;8(17):28826-28839. doi: 10.18632/oncotarget.16259.

48.

Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.

Yasuda K, Hirohashi Y, Mariya T, Murai A, Tabuchi Y, Kuroda T, Kusumoto H, Takaya A, Yamamoto E, Kubo T, Nakatsugawa M, Kanaseki T, Tsukahara T, Tamura Y, Hirano H, Hasegawa T, Saito T, Sato N, Torigoe T.

Oncotarget. 2017 May 9;8(19):31540-31553. doi: 10.18632/oncotarget.16361.

49.

A novel transperitoneal abdominal wall nerve block for postoperative pain in laparoscopic colorectal surgery.

Nagata J, Watanabe J, Sawatsubashi Y, Akiyama M, Arase K, Minagawa N, Torigoe T, Hamada K, Nakayama Y, Hirata K.

Asian J Surg. 2018 Sep;41(5):417-421. doi: 10.1016/j.asjsur.2017.02.006. Epub 2017 Apr 25.

50.

Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.

Shionoya Y, Kanaseki T, Miyamoto S, Tokita S, Hongo A, Kikuchi Y, Kochin V, Watanabe K, Horibe R, Saijo H, Tsukahara T, Hirohashi Y, Takahashi H, Sato N, Torigoe T.

Oncoimmunology. 2017 Jan 3;6(2):e1274476. doi: 10.1080/2162402X.2016.1274476. eCollection 2017.

Supplemental Content

Loading ...
Support Center